Location History:
- Union, NJ (US) (2002)
- Clark, NJ (US) (2003)
- Garwood, NJ (US) (2006)
Company Filing History:
Years Active: 2002-2006
Title: Celebrating the Innovations of Karen M. Conrad
Introduction
Karen M. Conrad, an inventive mind based in Garwood, NJ, has made significant contributions to pharmaceutical science through her innovative work. With a focus on compounds that address critical health issues, her patents highlight her dedication to improving the therapeutic landscape.
Latest Patents
Karen has been awarded three patents, showcasing her prowess in the field of medicinal chemistry. Her most recent patents include:
1. **Process and Intermediates for the Preparation of 4-Aryl Piperidines** - This novel process facilitates the preparation of 4-aryl piperidines, which serve as intermediates for synthesizing melanocortin-4 receptors (MC-4R). These compounds are particularly valuable for treating various disorders, including obesity, diabetes, and sexual dysfunction in both males and females.
2. **Process for the Synthesis of (2R, 2-alpha-R, 3A)-2-[1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine** - This invention presents innovative processes for creating (2R, 2-alpha-R, 3A)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine. This compound is recognized for its role as an intermediate in synthesizing pharmacologically active compounds.
Career Highlights
Karen M. Conrad currently works with Merck & Company, Inc., where her research and development efforts continue to revolutionize the pharmaceutical industry. Her contributions not only enhance the effectiveness of medications but also target a broader spectrum of health challenges.
Collaborations
Throughout her career, Karen has worked alongside esteemed colleagues, including Genevieve N. Boice and Edward G. Corley. These collaborations have fostered a rich environment for innovation, allowing them to combine expertise and insight to drive forward their scientific endeavors.
Conclusion
Karen M. Conrad's work exemplifies the essence of innovation in pharmaceuticals. Her patents reflect a commitment to creating impactful solutions for widespread health issues, making her a notable figure in the realm of medicinal chemistry. Through her contributions at Merck & Company, she continues to inspire future innovations in the field.